Cabozantinib for treating advanced neuroendocrine tumours that have progressed after systemic treatment ID6474Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 19 November 2025
Endoscopic bipolar radiofrequency ablation for treating biliary obstruction caused by cholangiocarcinoma or pancreatic adenocarcinomaStatus:In developmentProgramme:Interventional procedures guidanceExpected publication date: TBC
Pegylated liposomal irinotecan in combination for untreated metastatic pancreatic cancer [ID6461]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC